{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vehicle&page=8", "query": { "intervention": "Control Vehicle", "page": 8 }, "page_size": 10 }, "pagination": { "page": 8, "page_size": 10, "total_count": 1096, "total_pages": 110, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vehicle&page=9&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Control+Vehicle&page=7&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-18T05:51:29.190Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01849965", "title": "Phase 3 Study Evaluating Efficacy and Safety of DSC127 Compared With Vehicle and With Standard-of-care in Diabetic Foot Ulcers", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Diabetic Foot Ulcers" ], "interventions": [ { "name": "DSC127", "type": "DRUG" }, { "name": "placebo vehicle gel", "type": "DRUG" }, { "name": "Standard of Care gel, Aquasite", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Integra LifeSciences Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 396, "start_date": "2013-04", "completion_date": "2015-12", "has_results": false, "last_update_posted_date": "2017-12-12", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 33, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Castro Valley, California + 25 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01849965" }, { "nct_id": "NCT01145807", "title": "TDT 067 Onychomycosis Study", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Onychomycosis" ], "interventions": [ { "name": "TDT067", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Transfersome", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Celtic Pharma Development Services", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 738, "start_date": "2010-04", "completion_date": "2012-08", "has_results": false, "last_update_posted_date": "2012-08-01", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 1, "location_summary": "Albequerque, New Mexico", "locations": [ { "city": "Albequerque", "state": "New Mexico" } ], "official_url": "https://clinicaltrials.gov/study/NCT01145807" }, { "nct_id": "NCT01355471", "title": "Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rosacea" ], "interventions": [ { "name": "CD07805/47 Gel", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Galderma R&D", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 293, "start_date": "2011-05", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2021-02-18", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 12, "location_summary": "Hot Springs, Arkansas • Miami Beach, Florida • Newnan, Georgia + 9 more", "locations": [ { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "Newnan", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Warren", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT01355471" }, { "nct_id": "NCT05802173", "title": "Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alopecia, Androgenetic" ], "interventions": [ { "name": "TDM-105795, 0.0025%", "type": "DRUG" }, { "name": "TDM-105795, 0.02%", "type": "DRUG" }, { "name": "TDM-105795 topical vehicle solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Technoderma Medicines Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "MALE", "summary": "18 Years to 55 Years · Male only" }, "enrollment_count": 71, "start_date": "2023-03-06", "completion_date": "2024-01-29", "has_results": true, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 13, "location_summary": "North Little Rock, Arkansas • Rolling Meadows, Illinois • Plainfield, Indiana + 10 more", "locations": [ { "city": "North Little Rock", "state": "Arkansas" }, { "city": "Rolling Meadows", "state": "Illinois" }, { "city": "Plainfield", "state": "Indiana" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "New Orleans", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT05802173" }, { "nct_id": "NCT05603754", "title": "Safety and Efficacy of Lorecivivint (SM04690) for the Treatment of Knee Osteoarthritis (STRIDES)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "Lorecivivint", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biosplice Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 499, "start_date": "2022-11-18", "completion_date": "2024-02-20", "has_results": true, "last_update_posted_date": "2026-09-01", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 44, "location_summary": "Tucson, Arizona • Cerritos, California • La Mesa, California + 35 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Cerritos", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Norco", "state": "California" }, { "city": "Pomona", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT05603754" }, { "nct_id": "NCT06400459", "title": "IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "IVW-1001 Ophthalmic Eyelid Wipe 0.1%", "type": "DRUG" }, { "name": "IVW-1001 Ophthalmic Eyelid Wipe 0.2%", "type": "DRUG" }, { "name": "IVW-1001 Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "IVIEW Therapeutics Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2024-06-25", "completion_date": "2024-10-15", "has_results": true, "last_update_posted_date": "2026-02-12", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06400459" }, { "nct_id": "NCT04547686", "title": "Efficacy of a Smoke-Free Homes Intervention", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cessation, Smoking" ], "interventions": [ { "name": "Smoke-Free Homes Intervention", "type": "BEHAVIORAL" }, { "name": "Quitline", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 916, "start_date": "2020-11-11", "completion_date": "2025-07-27", "has_results": true, "last_update_posted_date": "2026-08-18", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT04547686" }, { "nct_id": "NCT05662202", "title": "Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED Lamp", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Actinic Keratoses" ], "interventions": [ { "name": "BF-200 ALA and red light LED lamp", "type": "COMBINATION_PRODUCT" }, { "name": "Vehicle and red light LED lamp", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "Biofrontera Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 172, "start_date": "2022-12-12", "completion_date": "2026-07-01", "has_results": true, "last_update_posted_date": "2026-08-21", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 14, "location_summary": "Phoenix, Arizona • Greenwood Village, Colorado • Delray Beach, Florida + 10 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Greenwood Village", "state": "Colorado" }, { "city": "Delray Beach", "state": "Florida" }, { "city": "Snellville", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05662202" }, { "nct_id": "NCT03065556", "title": "A Comparison of 188-0551 Solution Versus Vehicle Solution in Subjects With Plaque Psoriasis (Study 203)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Plaque Psoriasis" ], "interventions": [ { "name": "188-0551 Solution", "type": "DRUG" }, { "name": "Vehicle Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 89, "start_date": "2017-01-26", "completion_date": "2017-12-06", "has_results": false, "last_update_posted_date": "2018-08-10", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 1, "location_summary": "Arlington Heights, Illinois", "locations": [ { "city": "Arlington Heights", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03065556" }, { "nct_id": "NCT04893486", "title": "CODY: A Study Evaluating The Safety And Efficacy Of QTORIN 3.9% Sirolimus Topical Gel For The Prevention Of Basal Cell Carcinomas (BCCs) In Patients With Gorlin Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "BCCs in Gorlin Syndrome Patients" ], "interventions": [ { "name": "PTX-022", "type": "DRUG" }, { "name": "Vehicle comparator", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Palvella Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 73, "start_date": "2021-05-06", "completion_date": "2023-03-13", "has_results": false, "last_update_posted_date": "2024-08-29", "last_synced_at": "2026-10-18T05:51:29.190Z", "location_count": 14, "location_summary": "Scottsdale, Arizona • Hot Springs, Arkansas • Palo Alto, California + 11 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Palo Alto", "state": "California" }, { "city": "Orange Park", "state": "Florida" }, { "city": "Ormond Beach", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04893486" } ] }